The Lorazepam 1 mg/Diphenhydramine HCl 12.5 mg/Haloperidol 2 mg Suppository is a compounded medication designed to treat conditions such as insomnia, anxiety, schizophrenia, agitation, and delirium. This medication is carefully formulated and compounded at Bayview Pharmacy.

Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
The Lorazepam 1 mg/Diphenhydramine HCl 12.5 mg/Haloperidol 2 mg Suppository is a compounded medication designed to treat a range of conditions. This unique formulation combines three active ingredients: lorazepam, diphenhydramine HCl, and haloperidol. Each of these ingredients plays a crucial role in managing different symptoms and conditions.
Lorazepam, a benzodiazepine, is commonly used to manage anxiety, insomnia, and seizures. Haloperidol, an antipsychotic, is used in the treatment of schizophrenia, bipolar disorder, and Tourette's syndrome.
This medication is available in a suppository form, a solid dosage form that is inserted into a body cavity, typically the rectum or vagina. The suppository dissolves or melts to release the medication, allowing for local or systemic absorption. This method of delivery allows the medication to be absorbed directly into the bloodstream, providing quick relief from symptoms.
However, it is important to note that this medication should only be used under the supervision of a healthcare professional.
If you have any questions about this formulation or how it can be used to treat your condition, please reach out to us at Bayview Pharmacy. Our team of experienced pharmacists is here to provide the information and support you need.
This compounded formulation of Lorazepam 1 mg/Diphenhydramine HCl 12.5 mg/Haloperidol 2 mg Suppository is designed for insertion into a body cavity, typically the rectum or vagina, where it dissolves or melts to release medication. It is primarily used for the treatment of anxiety, insomnia, and psychotic disorders. Patients with a known hypersensitivity to any of the components should not use this formulation. Extra caution is advised for patients with a history of glaucoma, urinary retention, or narrow-angle glaucoma.
Patients are strongly advised to avoid alcohol and other CNS depressants while taking this formulation. Activities requiring mental alertness, such as operating a motor vehicle or machinery, should also be avoided until the patient understands how this formulation affects them.
Concomitant use of this formulation with other CNS depressants, such as opioids, sedatives, hypnotics, anxiolytics, and alcohol, may increase the risk of sedation, respiratory depression, and other adverse effects. Similarly, using this formulation alongside other antipsychotics may increase the risk of extrapyramidal symptoms, including akathisia, dystonia, and parkinsonism.
Using this formulation in conjunction with anticholinergic drugs may increase the risk of anticholinergic effects, such as dry mouth, blurred vision, constipation, and urinary retention. If used with MAO inhibitors, there may be an increased risk of serotonin syndrome. Using this formulation with anticoagulants may increase the risk of bleeding. Finally, using this formulation with drugs that are metabolized by the cytochrome P450 system may increase the risk of drug interactions.
If you have any questions about this formulation or its interactions, please do not hesitate to reach out for further information.
This compounded formulation of Lorazepam 1 mg/Diphenhydramine HCl 12.5 mg/Haloperidol 2 mg Suppository is designed to address a range of conditions such as anxiety, insomnia, and psychotic disorders. The Lorazepam component acts to alleviate anxiety and foster relaxation. The Diphenhydramine HCl is included to aid in sleep induction.
The suppository is administered rectally and is generally used for short-term treatment of the aforementioned conditions. For optimal results, the suppository should be inserted into the rectum and left in place for a minimum of 15 minutes before removal. It is crucial to remember that this formulation should not be used for more than two weeks without a doctor's consultation.
Common side effects associated with this formulation include drowsiness, dizziness, dry mouth, and constipation. Additionally, this formulation may cause an increase in blood pressure, making it essential to monitor blood pressure regularly while on this medication.
If you have any queries about this formulation or its mechanism of action, please do not hesitate to contact us. We are committed to assisting you in finding the most suitable treatment option for your condition.
This compounded formulation of Lorazepam 1 mg/Diphenhydramine HCl 12.5 mg/Haloperidol 2 mg Suppository is a versatile medication with a range of potential uses. It may be employed in the treatment of various conditions such as Tourette Syndrome, Obsessive Compulsive Disorder, and Post-Traumatic Stress Disorder. This formulation can also be beneficial in managing the symptoms of alcohol withdrawal, which may include agitation, tremors, and hallucinations.
Furthermore, this suppository formulation can be used to alleviate the symptoms of Parkinson’s Disease, such as tremors, rigidity, and difficulty with movement. It may also be beneficial in managing the symptoms of Huntington’s Disease, which can include involuntary movements, cognitive decline, and behavioral changes.
It is important to note that the use of this medication should always be under the guidance of a healthcare professional. If you have any questions or concerns about the use of this formulation for any of these conditions, please consult with your healthcare provider.
This is a compounded medication that combines Lorazepam, Diphenhydramine, and Haloperidol in a solid dosage form. It is designed to be inserted into a body cavity, typically the rectum or vagina, where it dissolves or melts to release the medication for local or systemic absorption.
This medication is typically used to manage symptoms of various conditions such as anxiety, insomnia, and psychotic disorders. The combination of these three active ingredients can provide a synergistic effect to manage these symptoms more effectively.
This suppository should be inserted into the rectum or vagina as directed by your healthcare provider. It is designed to dissolve or melt once inserted, releasing the medication for absorption.
Side effects can vary depending on the individual and the dosage. Common side effects may include drowsiness, dizziness, dry mouth, constipation, or blurred vision. If any of these effects persist or worsen, contact your healthcare provider immediately.
Before using this medication, inform your healthcare provider if you are pregnant or breastfeeding. The effects of this medication on an unborn baby or nursing infant are not fully known, so it is important to discuss the potential risks and benefits with your healthcare provider.
Before starting this medication, inform your healthcare provider about all the other medications you are currently taking. Some drugs may interact with this medication, which could increase your risk for serious side effects or alter the effectiveness of the medication.
If you miss a dose, use it as soon as you remember. If it is near the time of the next dose, skip the missed dose. Do not double the dose to catch up.
Store this medication at room temperature, away from light and moisture. Do not store in the bathroom. Keep all medications away from children and pets.
If someone has overdosed and has serious symptoms such as passing out or trouble breathing, call emergency services immediately. Otherwise, call a poison control center right away.
No, you should not stop using this medication abruptly without consulting your healthcare provider. Abruptly stopping the medication can lead to withdrawal symptoms. Your healthcare provider will guide you on how to safely discontinue the medication.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
This preparation is a controlled substance. Additional prescribing, refill, and shipping restrictions apply, and the states Bayview can dispense it to are narrower than for non-controlled preparations.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Insert 1 unwrapped suppository